-transparent.png){kind=logo}
The concentrations of antipyrine in plasma and saliva were equivalent in normal volunteers and in patients with acute viral hepatitis following oral doses of antipyrine. Estimates of clearance, volume of distribution, and half-life made from either plasma or saliva samples were not statistically different in these subjects. Differences in the disposition kinetics of anticted using either plasma or saliva samples.
Related Publications
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
August 1972,
Journal of pharmaceutical sciences,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
March 2009,
Antimicrobial agents and chemotherapy,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
February 1977,
British journal of clinical pharmacology,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
April 1976,
International journal of clinical pharmacology and biopharmacy,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
July 1997,
Clinical pharmacology and therapeutics,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
September 2006,
Statistics in medicine,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
November 1978,
British journal of clinical pharmacology,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
October 1977,
British journal of clinical pharmacology,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
June 1988,
British journal of clinical pharmacology,
P J Meffin, and
R L Williams, and
T F Blaschke, and
M Rowland
January 2006,
Postepy higieny i medycyny doswiadczalnej (Online),
